InMed Pharmaceuticals Inc. logo

INMInMed Pharmaceuticals Inc.

INM Stock Price, Valuation & Chart | InMed Pharmaceuticals Inc.

Compare

INM Historical price chart

INM Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization2.44M
PE Ratio-0.25
EPS-5.44
Trading Volume19.75K
Today's High/Low1.4/1.32
Dividend Yield0.00
52 Week High/Low2.5/0.57
Shares Outstanding1.81M
INM Financial Statement
INM Analyst ratings
INM Analysis & performance metrics

INM Company profile

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol…

INM Management team

Management
Ado Muhammad
Senior Consultant of Medical Affairs
Sazzad Hossain M.Sc., Ph.D.
Co-Founder
Colin ClancyCTO
Senior Director of Investor Relations
N. Netta JagpalCFO
Chief Financial Officer & Corporate Secretary
Eric A. Adams B.S. Chem., M.I.B.CEO
President, Chief Executive Officer & Director
Alexandra Diane-Janet Mancini M.Sc.
Senior Vice President of Clinical & Regulatory Affairs
Jerry P. Griffin
Vice President of Sales & Marketing
Shane A. Johnson Ph.D.
Senior Vice President & GM of BayMedica
Total 8 executives

INM Frequently asked questions

What is InMed Pharmaceuticals Inc. (INM) Stock Price?

Current stock price of InMed Pharmaceuticals Inc. (INM) stock is $1.350. The stock price is +2.27% higher in the session. The intraday range can be seen from this page. Volume of InMed Pharmaceuticals Inc. (INM) stock is 19.75K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the InMed Pharmaceuticals Inc. (INM) stock price going up or down today?

The stock price of InMed Pharmaceuticals Inc. (INM) can change with earnings, company news, and overall market sentiment. InMed Pharmaceuticals Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the InMed Pharmaceuticals Inc. stock expensive at its current price?

Whether InMed Pharmaceuticals Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for INM on this page is -0.25. EPS on this page is -5.44. Compare those figures with peers and growth expectations before deciding if the current InMed Pharmaceuticals Inc. price is justified.

How has the stock price of InMed Pharmaceuticals Inc. (INM) performed historically?

Historical performance for InMed Pharmaceuticals Inc. (INM) is shown on the price chart on this page. Review multi-period moves alongside volume to see how INM reacted to past earnings and market events.

Should I buy InMed Pharmaceuticals Inc. (INM) stock, at this price?

Buying InMed Pharmaceuticals Inc. (INM) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.